A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells.
bioRxiv
; 2021 May 06.
Article
in En
| MEDLINE
| ID: mdl-34131661